Results 51 to 60 of about 53,102 (149)

Antiplatelet and anticoagulant therapy in elderly people with type 2 diabetes mellitus in Poland (based on the PolSenior Study)

open access: yesArchives of Medical Science, 2017
Introduction: Type 2 diabetes mellitus (T2DM) is an important and common cardiovascular risk factor. The purpose of the study was to evaluate the frequency of use of oral antiplatelet drugs (OAPs) and oral anticoagulant drugs (OACs) among the elderly ...
Beata Łabuz-Roszak   +8 more
doaj   +1 more source

How to undertake procedures while on antiplatelet agents: a hematologist's view

open access: yesResearch and Practice in Thrombosis and Haemostasis
Cardiovascular diseases (CVDs) are the leading cause of mortality globally while also contributing to excess health system costs. Significant advancements have been made in the understanding and prevention of deaths from CVD.
Dawn Swan   +3 more
doaj   +1 more source

Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update

open access: yesVascular Health and Risk Management, 2010
Juan V Llau1, Raquel Ferrandis1, Pilar Sierra2, Aurelio Gómez-Luque31Department of Anaesthesiology and Critical Care Medicine, Hospital Clínic Universitari, València, Spain; 2Department of Anaesthesiology, Fundaci& ...
Juan V Llau   +3 more
doaj  

ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL?

open access: yesРациональная фармакотерапия в кардиологии, 2016
Mechanisms of atherothrombosis in atherosclerosis of coronary arteries are described. Mechanism of action and clinical efficiency of antithrombotic and antiplatelet medicines such as acetylsalicylic acid, warfarin, ticlopidine and clopidogrel are ...
I. A. Latfullin, A. A. Podolskaya
doaj   +1 more source

Evolving role of platelet function testing in coronary artery interventions

open access: yesVascular Health and Risk Management, 2012
Rakesh K Sharma1, Donald J Voelker1, Rohit Sharma1, Hanumanth K Reddy1, Harvinder Dod1, James D Marsh21Medical Center of South Arkansas, 2Division of Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR, USAAbstract: The substantial ...
Reddy HK   +5 more
doaj  

Antiplatelet Drugs and Its Gastrointestinal Side Effects among Ischemic Stroke Patients in Dr. Hasan Sadikin General Hospital 2011

open access: yesAlthea Medical Journal, 2015
Background: Antiplatelet drugs with known side effects are given in long term therapies to prevent secondary ischemic stroke. Gastrointestinal side effect is the most prevalent issue.
Ananthakrishnan A/L Rajendram   +2 more
doaj   +1 more source

Effects of Antiplatelet Drugs on Platelet-Dependent Coagulation Reactions. [PDF]

open access: yesBiomolecules, 2023
Muravlev IA   +6 more
europepmc   +1 more source

Antiplatelet drugs may increase the risk for checkpoint inhibitor-related pneumonitis in advanced cancer patients. [PDF]

open access: yesESMO Open, 2023
Araki T   +12 more
europepmc   +1 more source

A prospective cross-sectional study on drug utilization evaluation drugs in a cardiac specialized hospital

open access: yesJournal of Contemporary Pharmacy
A variety of illnesses that impact the heart and blood arteries are referred to as cardiovascular diseases. Patients with myocardial infarction (heart attack), angina pectoris, coronary heart disease, and stroke are often prescribed anticoagulant and ...
Rana Dawood Naseer   +2 more
doaj  

Home - About - Disclaimer - Privacy